Skip to main content
. Author manuscript; available in PMC: 2017 Sep 29.
Published in final edited form as: Bone Marrow Transplant. 2013 Oct 28;49(2):248–253. doi: 10.1038/bmt.2013.167

Figure 1.

Figure 1

Cumulative incidences of grade III–IV acute GVHD for TAC/MTX, TAC/μMTX/MMF and TAC/MMF. TAC/MMF results in significantly greater incidence of grade III–IV acute GVHD than TAC/MTX or TAC/μMTX/MMF (a) Acute GVHD organ involvement is greater for TAC/MMF than TAC/MTX or TAC/μMTX/MMF in the gastrointestinal tract (b) but not liver (c) or skin (d) thick line—TAC/MTX, dashed line—TAC/μMTX/MMF, thin line—TAC/MMF. Abbreviations: μMTX = micro-dose MTX (7.5 mg/m2); MMF = mycophenolate mofetil; MTX = standard-dose MTX (30–40 mg/m2); TAC = tacrolimus.